[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"status-days":3,"stock-4162":29,"stock-themes-4162":130},[4,18],{"date":5,"taiex_close":6,"taiex_chg":7,"taiex_chg_pct":8,"advancers":9,"decliners":10,"unchanged":11,"stocks":12,"turnover_sum":13,"margin_balance":14,"margin_chg":15,"short_balance":16,"short_chg":17},"2026-10-13",48341.31,-960.6500000000015,-0.019485026558781926,444,1337,161,1975,1309836115579,9070158,-104057,168869,-7061,{"date":19,"taiex_close":20,"taiex_chg":21,"taiex_chg_pct":22,"advancers":23,"decliners":24,"unchanged":25,"stocks":26,"turnover_sum":27,"margin_balance":28,"margin_chg":28,"short_balance":28,"short_chg":28},"2026-10-14",48625.83,284.5200000000041,0.0058856493545582644,1299,457,190,1970,1137851651667,null,{"profile":30,"snapshot":47,"data_version":129},{"code":31,"name":32,"full_name":33,"market":34,"kind":35,"industry":36,"listed_date":37,"chairman":38,"president":39,"capital":40,"shares":41,"founded_date":42,"website":43,"address":44,"english_name":45,"dividend_frequency":46},"4162","智擎","智擎生技製藥股份有限公司","otc","stock","生技醫療業","2012-09-18","許璋瑤","王宏仁",1436776400,143677640,"2002-08-12","https:\u002F\u002Fwww.pharmaengine.com","台北市民生東路3段10號11樓","PEI","每年",{"code":31,"name":32,"market":34,"kind":35,"industry":36,"close":48,"chg":49,"chg_pct":50,"ret_5d":51,"ret_20d":52,"volume":53,"turnover":54,"mcap":55,"signals":56,"as_of":19,"ref_price":59,"ret_60d":60,"ret_ytd":61,"open":62,"high":62,"low":63,"pe":64,"pb":65,"dy":66,"foreign_net_1d":67,"foreign_net_5d":68,"trust_net_1d":69,"trust_net_5d":69,"dealer_net_1d":70,"dealer_net_5d":71,"foreign_holding_pct":72,"margin_balance":73,"margin_chg":74,"short_balance":69,"short_chg":69,"large_holder_pct":75,"large_holder_chg_1w":76,"large_holder_chg_4w":77,"holders_date":78,"high_52w":79,"low_52w":80,"rev_period":81,"rev_yoy":82,"eps_period":83,"eps":84,"spark":85},56.8,0.30000000000000426,0.005309734513274433,0.032727272727272716,0.051851851851851816,91907,5225814,8160889952,[57,58],"rev_yoy","eps_yoy",56.49999999999999,-0.07864704822156698,-0.1663326274391168,57.3,56.5,15.35,1.66,3.52,-3570,-160570,0,-811,15205,11.69,2133,-7,38.08,-0.6400000000000006,-0.8999999999999986,"2026-10-09",74.4,53,"2026-09",13.07,"2026-Q2",0.9200796828064163,[86,87,88,89,90,91,86,92,93,94,95,96,97,98,97,99,97,100,101,102,103,104,105,106,107,108,104,109,110,107,104,111,112,113,113,114,115,116,117,118,119,117,120,116,121,116,122,123,124,125,121,126,125,127,127,116,128,62,63,48],64.3,68,68.4,66.8,65.9,65.8,63.5,61.5,61.4,62,63,63.7,63.2,64.7,62.9,63.6,62.1,59.1,59,58.2,59.3,60,59.2,60.1,60.5,58.4,57.7,57.8,57,56.4,55.8,54.8,54,54.1,54.6,55.6,56.3,56.2,55.5,55.4,55.3,55,57.2,"20261014-0f32f3",[131],{"theme":132,"segment":139,"tier":140,"role":141,"relevance":142,"note":143,"peers":144,"upstream":214,"downstream":221},{"id":127,"slug":133,"name":134,"category":135,"ret_1d":138},"new-drugs","新藥研發",{"slug":136,"name":137},"biotech","生技醫療",0.022403915208728437,"新藥開發與臨床","upstream","niche","high","新藥開發與授權",[145,161,171,182,192,204],{"code":146,"name":147,"role":148,"relevance":142,"note":149,"industry":36,"close":150,"chg_pct":151,"ret_5d":152,"ret_20d":153,"mcap":154,"turnover":155,"signals":156},"6446","藥華藥","leader","血液疾病新藥，已有上市產品",1190,0.021459227467810926,0.012765957446808418,-0.07031250000000011,502697216840,1307105205,[57,157,58,158,159,160],"rev_yoy_3m","foreign_buy_5d","trust_buy_5d","holders_up",{"code":162,"name":163,"role":141,"relevance":142,"note":164,"industry":36,"close":165,"chg_pct":166,"ret_5d":69,"ret_20d":167,"mcap":168,"turnover":169,"signals":170},"4743","合一","傷口與皮膚新藥",48.1,0.0115667718191379,0.0956719817767655,23113660676.600002,37416963,[58,158,160],{"code":172,"name":173,"role":141,"relevance":142,"note":174,"industry":36,"close":175,"chg_pct":176,"ret_5d":177,"ret_20d":178,"mcap":179,"turnover":180,"signals":181},"4147","中裕","愛滋病抗體藥，已有上市產品",60.4,0.036020583190394584,-0.014681892332789492,0.010033444816053505,16501426470,30788054,[],{"code":183,"name":184,"role":141,"relevance":185,"note":186,"industry":36,"close":118,"chg_pct":69,"ret_5d":187,"ret_20d":188,"mcap":189,"turnover":190,"signals":191},"1760","寶齡富錦","mid","腎臟病用藥與保健品",0.005586592178770999,-0.001848428835489857,4629906702,4519039,[57,58],{"code":193,"name":194,"role":195,"relevance":142,"note":196,"industry":36,"close":197,"chg_pct":198,"ret_5d":199,"ret_20d":200,"mcap":201,"turnover":202,"signals":203},"4174","浩鼎","challenger","癌症新藥開發",59.7,0.06989247311827973,0.17519685039370092,1.345776031434185,7855307313.900001,45664574,[58],{"code":205,"name":206,"role":195,"relevance":142,"note":196,"industry":36,"close":207,"chg_pct":208,"ret_5d":209,"ret_20d":210,"mcap":211,"turnover":212,"signals":213},"6550","北極星藥業-KY",16.1,0.012578616352201477,0.0031152647975078995,-0.1612954045382221,7484026138.400001,5597231,[58,158,160],[215],{"id":216,"slug":217,"name":218,"category":219,"ret_1d":220},56,"cdmo-generics","CDMO 與學名藥",{"slug":136,"name":137},0.006764771536201566,[]]